Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Intracranial Hemorrhage (ICH) In Patients (Pts) Presenting with Myeloid Leukemia to a Tertiary Care Center

Farshid Dayyani, Sarah Schellhorn Mougalian, MD, Kiran Naqvi, MD, Farhad Ravandi, MD, Jorge Cortes, MD, Elias Jabbour, MD, Stefan Faderl, MD, William G. Wierda, MD, PhD, Deborah A. Thomas, MD, Susan O'Brien, Sherry A. Pierce, RN, BS, Hagop Kantarjian, MD, Guillermo Garcia-Manero, MD

Blood (2010) 116 (21): 2170.

https://doi.org/10.1182/blood.V116.21.2170.2170

Published: 2010

Journal Articles

TLEs Regulate Myeloid Proliferation and Differentiation In Association with Modulation of NF-κB and Wnt Signaling

Jianfeng Wang, PhD, Farshid Dayyani, PhD, Christopher Brynzka, PhD, David Sweetser

Blood (2010) 116 (21): 4176.

https://doi.org/10.1182/blood.V116.21.4176.4176

Published: 2010

Journal Articles

Outcome of Therapy-Related Acute Promyelocytic Leukemia (t-APL) with or without Arsenic Trioxide (ATO) as a Component of Frontline Therapy.

Farshid Dayyani, MD, PhD, Hagop M. Kantarjian, MD, Susan O'Brien, M.D., Sherry Pierce, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Jorge Cortes-Franco, MD, Farhad Ravandi, MD

Blood (2009) 114 (22): 1050.

https://doi.org/10.1182/blood.V114.22.1050.1050

Published: 2009

Journal Articles

Groucho/TLE Corepressors Regulate Myeloid Differentiation and Size of the Stem Cell/Progenitor Population.

Jianfeng Wang, MD, PhD, Farshid Dayyani, MD, PhD, Christopher Brynczka, David A. Sweetser, MD, PhD

Blood (2008) 112 (11): 1396.

https://doi.org/10.1182/blood.V112.11.1396.1396

Published: 2008

Journal Articles

Disease-Related Mortality in Patients with Lower-Risk Myelodysplastic Syndrome (MDS)

Farshid Dayyani, MD, PhD, Anthony P Conley, MD, Sherry Pierce, RN, Sara Strom, PhD, William Stevenson, MBBS, PhD, Gautam Borthakur, MD, Hagop Kantarjian, MD, Guillermo Garcia-Manero, MD

Blood (2008) 112 (11): 5073.

https://doi.org/10.1182/blood.V112.11.5073.5073

Published: 2008

Journal Articles

Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias

Woo Jae Kim, Ross A. Okimoto, Louise E. Purton, Meagan Goodwin, Sara M. Haserlat, Farshid Dayyani, David A. Sweetser, Andrea I. McClatchey, Olivier A. Bernard, A. Thomas Look, Daphne W. Bell, David T. Scadden, Daniel A. Haber

Blood (2008) 111 (9): 4716–4722.

https://doi.org/10.1182/blood-2007-10-113068

Published: 2008

Includes: Supplemental data

Journal Articles

Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival

Farshid Dayyani, Jianfeng Wang, Jing-Ruey J. Yeh, Eun-Young Ahn, Erica Tobey, Dong-Er Zhang, Irwin D. Bernstein, Randall T. Peterson, David A. Sweetser

Blood (2008) 111 (8): 4338–4347.

https://doi.org/10.1182/blood-2007-07-103291

Published: 2008

Includes: Supplemental data

Journal Articles

The Groucho Corepressors, TLE1 and TLE4 , Are Candidate Del(9q) AML Tumor Suppressor Genes That Can Complement AML1-ETO .

David A. Sweetser, MD, PhD, Farshid Dayyani, MD, Jianfeng Wang, MD, PhD, Yuntian Zhang, MS, Tanweer Zaidi, PhD

Blood (2006) 108 (11): 1406.

https://doi.org/10.1182/blood.V108.11.1406.1406

Published: 2006

Journal Articles

TLE Corepressors as Novel Candidate AML Tumor Suppressor Genes That Regulate Wnt Signaling, Cell Cycle Progression, and Myeloid Differentiation.

Farshid Dayyani, MD, Yuntian Zhang, MS, Sayyed T. Zaidi, PhD, David A. Sweetser, MD, PhD

Blood (2005) 106 (11): 1601.

https://doi.org/10.1182/blood.V106.11.1601.1601

Published: 2005

Journal Articles

The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion–mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase

Ralf Schmidmaier, Philipp Baumann, Meral Simsek, Farshid Dayyani, Bertold Emmerich, Gerold Meinhardt

Blood (2004) 104 (6): 1825–1832.

https://doi.org/10.1182/blood-2003-12-4218

Published: 2004

NARROW

Intracranial Hemorrhage (ICH) In Patients (Pts) Presenting with Myeloid Leukemia to a Tertiary Care Center

TLEs Regulate Myeloid Proliferation and Differentiation In Association with Modulation of NF-κB and Wnt Signaling

Outcome of Therapy-Related Acute Promyelocytic Leukemia (t-APL) with or without Arsenic Trioxide (ATO) as a Component of Frontline Therapy.

Groucho/TLE Corepressors Regulate Myeloid Differentiation and Size of the Stem Cell/Progenitor Population.

Disease-Related Mortality in Patients with Lower-Risk Myelodysplastic Syndrome (MDS)

Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias

Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival

The Groucho Corepressors, TLE1 and TLE4 , Are Candidate Del(9q) AML Tumor Suppressor Genes That Can Complement AML1-ETO .

TLE Corepressors as Novel Candidate AML Tumor Suppressor Genes That Regulate Wnt Signaling, Cell Cycle Progression, and Myeloid Differentiation.

The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion–mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only